NexGel, Inc Common Stock (NXGL) is a publicly traded Healthcare sector company. As of May 19, 2026, NXGL trades at $0.61 with a market cap of $4.66M and a P/E ratio of -1.35. NXGL moved +9.57% today. Year to date, NXGL is -71.77%; over the trailing twelve months it is -78.80%. Its 52-week range spans $0.48 to $5.10. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces NXGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NEXGEL Patch Cuts Laser Plume 95.6%, Lowers Pain Scores by 31%: NEXGEL’s hydrogel patch cut laser plume concentration by 95.6% in a 30-patient IRB study and yielded a 37.2% mean hair density reduction at 90 days compared to 26.7% on the control side. Pain scores were 31% lower (3.5 vs 5.1) on treated sites with no adverse events reported.
| Metric | Value |
|---|---|
| Price | $0.61 |
| Market Cap | $4.66M |
| P/E Ratio | -1.35 |
| EPS | $-0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.10 |
| 52-Week Low | $0.48 |
| Volume | 388.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.42M |
| Net Income | $-2.89M |
| Gross Margin | 39.48% |
1 analysts cover NXGL: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.